Market Tracker

07/29 7:54am ET

Regeneron Pharmaceuticals Inc (NASDAQ:REGN)

411.04
Delayed Data
As of Jul 28
 -4.05 / -0.98%
Today’s Change
329.09
Today|||52-Week Range
605.93
-24.28%
Year-to-Date
3 Drugs Stocks Pushing Industry Growth
Jul 27 / TheStreet.com - Paid Partner Content
3 Biotech Stocks to Buy and Hold
Jul 19 / MotleyFool.com - Paid Partner Content
Jim Cramer's 'Mad Money' Recap: Here's What I'm Watching Next Week
Jul 22 / TheStreet.com - Paid Partner Content
Wall Street set for best week since late 2014 as stocks rebound
Jul 01 / FT.com - Paid Partner Content
Why I Bought Shares of Regeneron Pharmaceuticals Inc. Last Week
Jul 20 / MotleyFool.com - Paid Partner Content
 

Today’s Trading

Previous close415.09
Today’s open413.81
Day’s range405.54 - 413.97
Volume623,765
Average volume (3 months)902,952
Market cap$43.6B
Dividend yield--
Data as of 07/28/2016

Growth & Valuation

Earnings growth (last year)+79.80%
Earnings growth (this year)-9.59%
Earnings growth (next 5 years)+20.00%
Revenue growth (last year)+45.55%
P/E ratio65.1
Price/Sales15.24
Price/Book11.89

Competitors

 Today’s
change
Today’s
% change
ALXNAlexion Pharmaceutic...+0.62+0.48%
SHPGShire-3.01-1.55%
ZTSZoetis Inc+0.21+0.42%
MYLMylan NV-0.21-0.45%
Data as of 07/28/2016

Financials

Next reporting dateAugust 2, 2016
EPS forecast (this quarter)$2.65
Annual revenue (last year)$4.1B
Annual profit (last year)$636.1M
Net profit margin15.50%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Leonard S. Schleifer
Chief Financial Officer &
Senior VP-Finance
Robert E. Landry
Corporate headquarters
Tarrytown, New York

Forecasts